Abbott Laboratories, Inc. (ABT) recently announced the first patient procedures with its investigational transcatheter aortic valve implantation (TAVI) balloon-expandable system for treating symptomatic severe aortic stenosis. The system is designed to build a foundation for artificial intelligence (AI) guided procedures.The investigational TAVI system will complement Abbott's Navitor TAVI system for aortic stenosis. The latest investigational TAVI system is aimed at expanding Abbott's structural heart port ...